Aurinia Pharmaceuticals (AUPH) Gross Profit (2020 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Gross Profit came in at $71.2 million in Q1 2026, up 32.12% YoY from $53.9 million in Q1 2025, and up 4.22% on a QoQ basis from $68.3 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Gross Profit (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 7 years of Gross Profit data on file, last reported at $71.2 million in Q1 2026.
- Quarterly Gross Profit rose 32.12% year-over-year to $71.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $267.7 million (up 22.67% YoY) and the FY2025 annual result came in at $250.4 million, up 21.03% from the prior year.
- Gross Profit improved to $71.2 million in Q1 2026, from $68.3 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $71.2 million in Q1 2026 to a low of $21.4 million in Q1 2022.
- A 5-year average of $48.1 million and a median of $48.3 million in 2024 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2022 — Gross Profit soared 2367.55% — and 2023, when it dropped 10.47%.
- Tracing AUPH's Gross Profit over 5 years: stood at $27.1 million in 2022, then jumped by 46.64% to $39.7 million in 2023, then surged by 36.81% to $54.3 million in 2024, then gained by 25.78% to $68.3 million in 2025, then grew by 4.22% to $71.2 million in 2026.
- The last three Gross Profit figures came in at $71.2 million (Q1 2026), $68.3 million (Q4 2025), and $65.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 76.67 Mn |
| Jun 30, 2026 | 76.67 Mn |
| Mar 31, 2026 | 71.20 Mn |
| Mar 31, 2026 | 71.20 Mn |
| Dec 31, 2025 | 68.32 Mn |
| Dec 31, 2025 | 68.32 Mn |
| Sep 30, 2025 | 65.29 Mn |
| Sep 30, 2025 | 65.29 Mn |
| Jun 30, 2025 | 62.89 Mn |
| Jun 30, 2025 | 62.89 Mn |
| Mar 31, 2025 | 53.89 Mn |
| Mar 31, 2025 | 53.89 Mn |
| Dec 31, 2024 | 54.32 Mn |
| Dec 31, 2024 | 54.32 Mn |
| Sep 30, 2024 | 61.74 Mn |
| Sep 30, 2024 | 61.74 Mn |
| Jun 30, 2024 | 48.28 Mn |
| Jun 30, 2024 | 48.28 Mn |
| Mar 31, 2024 | 42.55 Mn |
| Mar 31, 2024 | 42.55 Mn |